reports
Alpine Select AG: 1 director
A director at Alpine Select AG bought 2,067 shares at 7.500CHF and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwr...
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, CEO and Chairman of the Board will participate in a virtual fireside chat with H.C. Wainwright & Co. on December 16, 2024. Biotech Equity Research Analyst, Emily Bodnar, will moderate the HCW@Home session which is scheduled to begin at 11:00 a.m. ET. The discussion will focus on the company’s clinical program of its lead candidate, Olvi-Vec, including its o...
Macerich Announces Pricing of Upsized Public Offering of Common Stock
Macerich Announces Pricing of Upsized Public Offering of Common Stock SANTA MONICA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) announced today that it has priced an underwritten public offering of 20,000,000 shares of common stock at a price to public of $19.75 per share for expected gross proceeds of approximately $395.0 million. The Company has also granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of its common stock. This reflects an upsizing of the previously announced offering of 18,00...
Macerich Announces Commencement of Public Offering of Common Stock
Macerich Announces Commencement of Public Offering of Common Stock SANTA MONICA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) announced today that it has commenced an underwritten public offering of 18,000,000 shares of common stock. The Company expects to grant the underwriters a 30-day option to purchase up to 2,700,000 additional shares of its common stock. The Company intends to use the net proceeds of this offering together with cash on hand, including from recent sales under the Company’s “at the market” offering program, ...
Genelux Corporation Reports Third Quarter 2024 Financial Results and P...
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates WESTLAKE VILLAGE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third quarter of 2024 and provided general business updates. The Company initiated its second lung cancer trial, a US-based, Phase 2 trial (VIRO-25) treating patients with recurrent advanced or metastatic non-small cell lung cancer (NSCLC) with Olvi-Vec, followed by platinum-doublet chemotherapy + immune checkpoint inhi...
Genelux Corporation to Participate in Fireside Chat at the Guggenheim ...
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference WESTLAKE VILLAGE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, CEO and Chairman of the Board, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference, taking place November 11-13, 2024, in Boston, Massachusetts. The conversation with Brittany Stopa, MD, Biotech Equity Research ...
Macerich Reports Third Quarter 2024 Results
Macerich Reports Third Quarter 2024 Results SANTA MONICA, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has released its Third Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at . As previously announced, management will hold a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) today, Wednesday, November 6, 2024, to discuss quarterly results. Participants who wish to join the conference by telephone must register using the dial-in registration link below to receive the ...
The Macerich Company Announces CFO Change
The Macerich Company Announces CFO Change Dan Swanstrom Named as Chief Financial Officer of The Macerich Company SANTA MONICA, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) today announced that Daniel E. Swanstrom II will become the Chief Financial Officer of Macerich effective on November 16, 2024. “I am very pleased to welcome Dan to Macerich,” said Jack Hsieh, Macerich’s CEO. “Dan brings an excellent background to Macerich with over 20 years of experience in real estate, both as a CFO of two public REITs and as a former inve...
American Homes 4 Rent: 1 director
A director at American Homes 4 Rent sold 100,000 shares at 35.195USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
GRESB Real Estate Assessment Ranks Macerich #1, U.S. Retail, for 10th ...
GRESB Real Estate Assessment Ranks Macerich #1, U.S. Retail, for 10th Consecutive Year Leading Retail REIT Again Recognized by Respected Sustainability Assessment for Industry-Leading Commitment to Performance and ESG Practices SANTA MONICA, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- (NYSE: ), one of the nation’s leading owners, operators and developers of major retail properties in top markets, has earned the #1 ranking among all U.S. retail in the GRESB Real Estate Assessment for the 10th consecutive year. Macerich ranked #3 in Retail, Americas, and earned the prestigious GRESB Green...
Macerich Declares the Quarterly Dividend on Its Common Shares
Macerich Declares the Quarterly Dividend on Its Common Shares SANTA MONICA, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $.17 per share of common stock. The dividend is payable on December 2, 2024, to stockholders of record at the close of business on November 12, 2024. About Macerich Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attracti...
Macerich Refinances Top-Performing Queens Center at Favorable Terms
Macerich Refinances Top-Performing Queens Center at Favorable Terms 5.37% Fixed Rate for 5 Years, Interest Only, on $525M Loan Lowest Refi Rate Achieved by Company in Past 5 Years SANTA MONICA, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- (NYSE: ), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced that it has refinanced fortress property Queens Center at highly favorable terms with a new $525 million loan bearing fixed interest of 5.37% and interest-only payments during the entire term. “We are pleased to share detai...
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Eva...
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer – VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician's choice of immune checkpoint inhibitor compared to docetaxel in recurrent non-small cell lung cancer – – Trial represents second indication in the clinic for Olvi-Vec via systemic administration – – Interim readout expected mid-2025 – WESTLAKE VILLAGE, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late-stage clinical i...
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtua...
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, CEO and Chairman of the Board, will participate at the 2024 Maxim Healthcare Virtual Summit taking place October 15-17, 2024. Mr. Zindrick will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat with Jason McCarthy, Ph.D., Senior Managing Director, Head of Biotechnology Research, which is scheduled for 2:00 p...
Macerich Schedules Third Quarter 2024 Earnings Release and Conference ...
Macerich Schedules Third Quarter 2024 Earnings Release and Conference Call SANTA MONICA, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules Third Quarter 2024 Earnings Release and Conference Call WHEN: Earnings Results will be released before market open on Wednesday, November 6, 2024. Management will hold a conference call at 10:00 am Pacific Time (1:00 pm Eastern Time) on that same day to discuss quarterly results. WHERE: Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-in n...
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
I3N CHART INDUSTRIES INC.
BEN FRANKLIN RESOURCES INC.
HTLD HEARTLAND EXPRESS INC.
RIGN TRANSOCEAN LTD.
CLAR CLARUS CORPORATION
STIM STIMSONITE CORP
U UNITY SOFTWARE INC.
GRNT GRANIT SKOPKE
TDUP THREDUP INC.
GNLX GENELUX CORP
BTSG BRIGHTSPRING HEALTH SERVICES INC.
- Jonathan Moreland
PSEC PROSPECT CAPITAL CORPORATION
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
CTRN CITI TRENDS INC.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
MYRG MYR GROUP INC.
HLT HILTON WORLDWIDE HOLDINGS INC
CNX CONSOL ENERGY INC.
ZM ZOOM VIDEO COMMUNICATIONS
GRNT INC.
FTHY GRANIT SKOPKE
PFHC FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
GNLX PROFRAC HLDG CORP
NPWR GENELUX CORP
PEO NET POWER INC
PETROLEUM & RESOURCES CORPORATION
- Jonathan Moreland
Macerich to Present at BofA Securities 2024 Global Real Estate Confere...
Macerich to Present at BofA Securities 2024 Global Real Estate Conference SANTA MONICA, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) today announced that Jack Hsieh, President and Chief Executive Officer, Scott Kingsmore, Senior Executive Vice President and Chief Financial Officer, and Doug Healey, Senior Executive Vice President Leasing will present to/speak with investors at BofA Securities 2024 Global Real Estate Conference in New York, NY September 10-11, 2024. Macerich will present at 1:30 p.m. Eastern on Tuesday, September 10, 2024. The live audio...
Genelux Corporation to Present at the H.C. Wainwright Global Investmen...
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference WESTLAKE VILLAGE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, Chairman and CEO, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at the H.C. Wainwright Global Healthcare Conference, taking place September 9-11, 2024, in New York City, New York. The conversation with Emily Bodnar, Vice President, Equity Research and H.C. Wainwright Biotechnology Analyst, is s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.